文献速递呼吸衰竭与机械通气创伤与烧伤重症综合管理与镇静镇痛

创伤相关急性呼吸窘迫综合征2007-2019:患者与中心层面的回顾性队列分析

Acute Respiratory Distress Syndrome in Trauma 2007-2019: Comprehensive Patient and Center-Level Retrospective Cohort Analysis.
PubMed 文献 · Crit Care Med · 2025-11-12
一句话结论创伤机械通气≥2天患者中ARDS发生率从2007年22/100降至2019年3/100,但粗死亡率升至29.7%,校正后ARDS独立关联30天院内死亡(OR 1.32)。

该回顾性队列研究基于美国外科医师学会国家创伤数据库,纳入2007-2019年≥18岁、机械通气≥2天的创伤患者384,032例,其中ARDS 29,359例(8/100机械通气患者)。ARDS发生率从2007年22/100显著降至2019年3/100(p<0.001)。粗ARDS死亡率从2007年15.1%升至2019年29.7%(p<0.001),校正后ARDS独立关联30天院内死亡(OR 1.32;95%CI 1.27-1.37)。在具有输血数据的亚组中,24小时血浆(OR 1.02;95%CI 1.01-1.04)和血小板(OR 1.03;95%CI 1.02-1.05)独立关联ARDS。

要点

  • 创伤机械通气≥2天患者中ARDS发生率为8/100,发生率从2007年22/100降至2019年3/100(p<0.001)。
  • 校正混杂后ARDS独立关联30天院内死亡(OR 1.32;95%CI 1.27-1.37),粗死亡率从2007年15.1%升至2019年29.7%。
  • ARDS患者中30天死亡独立危险因素包括颅脑损伤(OR 1.54;95%CI 1.43-1.66)、严重脓毒症(OR 1.48;95%CI 1.34-1.63)、急性肾损伤(OR 2.72;95%CI 2.50-2.96)。
  • 在预防与早期治疗急性肺损伤及体外生命支持组织中心管理的ARDS患者死亡可能性更低(OR 0.78;95%CI 0.72-0.84)。
  • 患者层面独立关联ARDS的因素:钝性损伤(OR 1.25;95%CI 1.20-1.30)、严重脓毒症(OR 2.16;95%CI 2.06-2.27)、呼吸机相关性肺炎(OR 2.91;95%CI 2.82-3.00)、急性肾损伤(OR 2.98;95%CI 2.85-3.12)。

适用人群与场景

  • 2007至2019年美国外科医师学会国家创伤数据库收录的≥18岁创伤患者,且机械通气≥2天。
  • ARDS患者与无ARDS患者进行比较;另识别具有输血数据的亚组。

研究设计与关键结果

  • 回顾性队列研究,纳入384,032例机械通气≥2天的创伤患者,ARDS记录于29,359例(8/100机械通气患者),发生率从2007年22/100降至2019年3/100(p<0.001)。
  • 患者层面独立关联ARDS的因素:钝性损伤(OR 1.25;95%CI 1.20-1.30)、严重脓毒症(OR 2.16;95%CI 2.06-2.27)、呼吸机相关性肺炎(OR 2.91;95%CI 2.82-3.00)、急性肾损伤(OR 2.98;95%CI 2.85-3.12)。
  • 输血亚组中,24小时血浆(OR 1.02;95%CI 1.01-1.04)和血小板(OR 1.03;95%CI 1.02-1.05)独立关联ARDS。
  • 粗ARDS死亡率从2007年15.1%升至2019年29.7%(p<0.001);校正显著差异后,ARDS独立关联30天院内死亡(OR 1.32;95%CI 1.27-1.37)。
  • ARDS患者30天死亡独立危险因素:颅脑损伤(OR 1.54;95%CI 1.43-1.66)、严重脓毒症(OR 1.48;95%CI 1.34-1.63)、急性肾损伤(OR 2.72;95%CI 2.50-2.96)。
  • 在预防与早期治疗急性肺损伤及体外生命支持组织中心管理的ARDS患者死亡可能性更低(OR 0.78;95%CI 0.72-0.84)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为未来研究应探讨可改变的患者与中心层面因素,以改善这些高危患者的死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Acute respiratory distress syndrome (ARDS) represents a significant complication in trauma patients. Yet the epidemiology of ARDS in trauma remains incompletely characterized. We sought to define trends in ARDS frequency and the effect of temporal, patient, and center-level factors on outcomes with the hypothesis that ARDS independently predicts mortality.

DESIGN: Retrospective cohort study.

SETTING: Hospitals submitting data to the American College of Surgeons National Trauma Data Bank.

PATIENTS: Injured patients 18 years old or older from 2007 to 2019 on mechanical ventilation (MV) for greater than or equal to 2 days were included, and patients with ARDS were compared with those without ARDS. A subgroup with transfusion data was also identified. Multivariable logistic regression models by year adjusted for patient demographics, center characteristics, and blood products identified factors independently associated with ARDS diagnosis and 30-day hospital mortality.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Of 384,032 injured patients on MV, ARDS was documented in 29,359 (8 per 100 MV patients) with a significant decrease over the study period (22 in 2007 vs. 3 in 2019, p < 0.001). Patient-level risk factors independently associated with ARDS were blunt injury (odds ratio [OR] 1.25; 95% CI, 1.20-1.30), severe sepsis (OR 2.16; 95% CI, 2.06-2.27), ventilator-associated pneumonia (OR 2.91; 95% CI, 2.82-3.00), and acute kidney injury (AKI, OR 2.98; 95% CI, 2.85 to 3.12). In the transfusion subset, 24-hour plasma (OR 1.02; 95% CI, 1.01-1.04) and platelets (OR 1.03; 95% CI, 1.02-1.05) were independently associated with ARDS. Crude ARDS mortality increased over the study period (2007, 15.1% vs. 2019, 29.7%, p < 0.001), and after adjusting for significant differences, ARDS was independently associated with 30-day hospital mortality (OR 1.32; 95% CI, 1.27-1.37). Independent risk factors for 30-day mortality in patients with ARDS included head injury (OR 1.54; 95% CI, 1.43-1.66), severe sepsis (OR 1.48; 95% CI, 1.34-1.63), and AKI (OR 2.72; 95% CI, 2.50-2.96). Patients with ARDS managed in Prevention and Early Treatment of Acute Lung Injury and the Extracorporeal Life Support Organization centers were less likely to die (OR 0.78; 95% CI, 0.72-0.84).

CONCLUSIONS: From 2007 to 2019, ARDS decreased significantly in trauma patients. Over the same time, mortality increased to nearly 30%, and after adjusting for other risks factors, ARDS was strongly associated with 30-day mortality. Future studies should examine modifiable patient and center-level factors to improve mortality in these high-risk patients.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Geng Z, Hynes AM, Moren AM, et al. Acute Respiratory Distress Syndrome in Trauma 2007-2019: Comprehensive Patient and Center-Level Retrospective Cohort Analysis. Crit Care Med. 2025. PMID: 41222422. doi:10.1097/CCM.0000000000006936

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。